Cani L, Scott SA, Roberts D, Joseph NS, Hofmeister CC, Gupta VA, Dhodapkar MV, Lonial S, Nooka AK, Kaufman JL. Infection risk in 158 patients with relapsed/refractory multiple myeloma treated with bispecific antibodies: a single-center experience. haematol [Internet]. 2026Feb.1 [cited 2026Feb.4];111(2):656-64. Available from: https://haematologica.org/article/view/12256